The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Age-related clonal hematopoiesis
Open accessAbstract
Age-related alterations in the human blood system occur in B cells, T cells, cells of the innate system, as well as hematopoietic stem and progenitor cells (HSPCs). Interestingly, age-related, reduced genetic diversity can be identified at the stem cell level and also independently in B cells and T cells. This reduced diversity is most probably related to somatic mutations or to changes in the microenvironmental niche. Either process can select for specific clones or cause repeated evolutionary bottlenecks. This review discusses the age-related clonal expansions in the human HSPC pool, which was termed in the past age-related clonal hematopoiesis (ARCH). ARCH is defined as the gradual, clonal expansion of HSPCs carrying specific, disruptive, and recurrent genetic variants, in individuals without clear diagnosis of hematological malignancies. ARCH is associated not just with chronological aging but also with several other, age-related pathological conditions, including inflammation, vascular diseases, cancer mortality, and high risk for hematological malignancies. Although it remains unclear whether ARCH is a marker of aging or plays an active role in these various pathophysiologies, it is suggested here that treating or even preventing ARCH may prove to be beneficial for human health. This review also describes a decision tree for the diagnosis and follow-up for ARCH in a research setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to microglia, MoM F are due to their derivation from HSC exposed to effects of somatic mutations that are associated with age-related clonal hematopoiesis (CH) 29,30 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Self-citation
Research works printed but not linked: 1
- Young, 2016, Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults, Nat Commun, 7, 12484, 10.1038/ncomms12484 · DOI · Paper page
Cited by
Sorted by citations
Items 201–281 of 281
Kitakaze, M., Chijimatsu, R., Vecchione, A. M., Kitagawa, T., Doki, Y., Eguchi, H., & Ishii, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147544 · Cited by 3
Stolzenbach, V., Woods, D. C., & Tilly, J. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.942652 · Cited by 3
3D Bioprinting as a Designer Organoid to Assess Pathological Processes in Translational Medicine
Rameshwar, P., Savanur, V. H., Etchegaray, J., & Güvendiren, M. (2022) · Journal of 3D Printing in Medicine · doi:10.2217/3dp-2021-0006 · Cited by 3
Bogdanov, A. N., Shcherbak, S. G., & Pavlovic, D. (2018) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov201810219-26 · Cited by 3
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer
Zuriaga, M. A., & Fuster, J. J. (2023) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2023.02.004 · Cited by 3
Razanamahery, J., Samson, M., Guy, J., Racine, J., Row, C., Greigert, H., Nicolas, B., François, S., Emile, J., Aubart, F. C., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.282739 · Cited by 3
The phenomenon of clonal hematopoiesis: etiology, classification and its prognostic role
Kunevich, E. O., Mikhaleva, M., Крысюк, О. Б., Bogdanov, A. N., Zherniakova, A., & Волошин, С. В. (2025) · Oncohematology · doi:10.17650/1818-8346-2025-20-1-28-54 · Cited by 2
Fu, M. P., Sharma, M., Yousefi, P., Merrill, S. M., Tan, R., Samra, S., Setiadi, A., Golding, L., Modi, B. P., Bel, K. L. D., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20240945 · Cited by 2
Schmid, C. N., Sponagel, K., Bacher, U., Seipel, K., Porret, N. A., Wiedemann, G., Hoffmann, M., Daskalakis, M., & Pabst, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168021 · Cited by 4
Blood-based epigenetic instability linked to human aging and disease
Basrai, S., Nofech-Mozes, I., Detroja, R., Scolari, F. L., Bakhtiari, M., Arruda, A., Murphy, T., Bratman, S. V., Chan, S. M., Minden, M. D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69430-z · Cited by 4
Singh, P. P., Tanwar, V., Xiang, Y., Najera, L. E., Austad, S. N., & Kapahi, P. (2026) · Cell · doi:10.1016/j.cell.2026.07.013 · Cited by 3
AML: Predicting the Unpredictable
Takahashi, K. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.07.005 · Cited by 2
O’Sullivan, B., & Seoighe, C. (2020) · Cancer Informatics · doi:10.1177/1176935120972377 · Cited by 2
Id1 promotes clonal hematopoiesis in mice with Tet2 loss of function
Singh, S., Gudmundsson, K. O., Sarkar, T., Jakubison, B. L., Morris, H. M., Burkett, S. S., Karim, B. O., Pauly, G. T., Sigano, D. M., Schneider, J. P., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr5867 · Cited by 4
Abdelkarim, M., Kharrat, R., Lakhal, F. B., Sioua, H., Limam, I., Neji, H. B., & Gouider, E. (2025) · Medical Oncology · doi:10.1007/s12032-025-03104-6 · Cited by 2
Dong, Y., Guo, C., Zhou, W., Li, W., & Zhang, L. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02455-x · Cited by 3
RetractedClonal hematopoiesis sees Twin Peaks
Shlush, L. I. (2020) · Blood · doi:10.1182/blood.2019003869 · Cited by 2
Self-citationLantéri, E., Hofman, V., Bontoux, C., Goffinet, S., Macocco, A., Long-Mira, É., Lassalle, S., Ilié, M., & Hofman, P. M. (2021) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(21)00378-6 · Cited by 3
Monitoring Measurable Residual Disease in ALL and AML
Bader, P., Kreyenberg, H., & Ossenkoppele, G. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-44080-9_57 · Cited by 1
Kartal‐Kaess, M., Karow, A., Bacher, U., Pabst, T., Joncourt, R., Zweier, C., Kuehni, C. E., Porret, N. A., & Roessler, J. (2024) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2024.2362885 · Cited by 2
The Primary Role of Noncoding RNA in the Pathogenesis of Cancer
Shah, A. (2025) · Genes · doi:10.3390/genes16070771 · Cited by 1
Kumar, A. A., Lam, A. K.-Y., & Gopalan, V. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102909 · Cited by 1
Association Between JAK2 V617F Somatic Mutation and Thoracic Aortic Aneurysms
Collins, S., Zafar, M. A., & Elefteriades, J. A. (2026) · Genes · doi:10.3390/genes17040364 · Cited by 1
Gateways for myeloid cell entry into the central nervous system
Amann, L., & Prinz, M. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.001 · Cited by 2
Leukemia - From Biology to Clinic
Guenova, M. L., & Balatzenko, G. N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100848 · Cited by 1
Common in atherogenesis and carcinogenesis: clonal hematopoiesis
Слепцов, А. А., Nazarenko, M. S., & Puzyrev, V. P. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5511 · Cited by 4
Lin, R. J. (2024) · Springer eBooks · doi:10.1007/978-3-030-74720-6_82 · Cited by 1
Lopedote, P., Evans, B., Marchetti, A., Chen, T., Moscvin, M., Boullt, S., Bolli, N., & Bianchi, G. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024012840 · Cited by 1
Genomic differences of patients with hematologic malignancies in different age groups
Yang, X., Wang, Q., Sun, Y.-H., Zhang, Z., Wuchty, S., Liang, Z., & Dong, Y. (2024) · Communications Biology · doi:10.1038/s42003-024-07293-0 · Cited by 2
Assessing Measurable Residual Disease in Acute Myeloid Leukemia
Duncan, D., Zeidner, J., & Montgomery, N. D. (2019) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2019.07.003 · Cited by 1
Management of Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Gupta, G., & Garg, V. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109700 · Cited by 1
Clonal Hematopoiesis and Cytopenias in the Elderly
Guy, D. G., Afzal, A., & Jacoby, M. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-96487-4_12
Feldman, T., Bercovich, A., Moskovitz, Y., Chapal-Ilani, N., Mitchell, A., Medeiros, J. J. F., Kaushansky, N., Biezuner, T., Minden, M. D., Gupta, V. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.01.888610
Self-citationOvert and Masked Polycythemia Vera Within the Scope of Ph-Negative Myeloproliferative Diseases
Tratsevskaya, Z. V., Kovrigina, A. M., Chebоtarev, D. I., Melikyan, A. L., Абдуллаев, А. О., & Sudarikov, A. B. (2020) · Clinical oncohematology · doi:10.21320/2500-2139-2020-13-1-58-66
Unconventional Diagnosis Based on Somatic Findings through Germ Line Whole-Exome Sequencing
Lopes, J. L., Rasmussen, K. J., Mehta, N. N., Boczek, N. J., & Hasadsri, L. (2019) · Clinical Chemistry · doi:10.1093/clinchem.2019.304451
Physiologic and pathologic profiling of clonal variations
Wong, W. (2019) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/scfg-zs49
Characterising the role of Zeb1 in the adult haematopoietic system
Almotiri, A. (2019) · ORCA Online Research @Cardiff (Cardiff University)
[Clonal evolution of myelodysplastic syndrome].
Luo, B., Dong, F., & Ema, H. (2019) · PubMed · doi:10.3760/cma.j.issn.0253-2727.2019.12.021
Demidov, O. N., Shakula, A. V., Гулеватый, Г. В., & Sobolev, A. V. (2020) · Bulletin of Rehabilitation Medicine · doi:10.38025/2078-1962-2020-97-3-45-49
[Progress in pre-myelodysplastic syndrome conditions].
Zhang, W., & Fu, R. (2020) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2020.07.014
A meghatározatlan jelentőségű klonális hemopoesis (CHIP) aktuális kérdései – irodalmi áttekintés
Jakó, J., & Szerafin, L. (2020) · Hematológia–Transzfuziológia · doi:10.1556/2068.2020.53.2.7
Vormittag-Nocito, E. R., Khan, I., Wiley, E. L., Behm, F. G., & Ni, H. (2020) · SAGE Open Medical Case Reports · doi:10.1177/2050313x20957446
Greco, S. J., Ayer, S., Guiro, K., Sinha, G., DONNELLY, R. J., El-Far, M. H., Sherman, L. S., Pamarthi, S. H., Gergues, M., Sandiford, O. A., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3862822
Klonale Hämatopoese – Verbindungsglied kardiovaskulärer und hämatologischer Erkrankungen
Frick, M., & Damm, F. (2022) · Transfusionsmedizin · doi:10.1055/a-1720-8217
Exploration of HSPC aging mechanism based upon in vitro cell modeling and MDS clinical samplingPreprint
Hu, H., Song, X., Zhao, L., Hu, L., Chu, X., Lin, L., Zhou, M., Lian, X., & Zhang, L. (2022) · Research Square · doi:10.21203/rs.3.rs-2007552/v1
Clonal Hematopoiesis in Cancer
Rauch, P. J., & Steensma, D. P. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm145
Diagnosis, classification, and prognosis of myelodysplastic syndromes
Bogdanovic, A. D., Marisavljević, D., & Savić, A. (2022) · Medicinski pregled · doi:10.2298/mpns22s1025b
Pojeti, R. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.74400
Lin, R. J. (2023) · Springer eBooks · doi:10.1007/978-3-030-01782-8_82-1
Evolution of clonal hematopoiesis
van Zeventer, I. A., de Graaf, A. O., Jansen, J. H., & Huls, G. A. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1444
Reversing the Aged Immune System with Stem Cells
Sherman, L. S., Petryna, A., Munoz, S. M., Gubenko, E. E., & Rameshwar, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_27-1
Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
Odetola, O. E., & Abaza, Y. (2024) · Advances in Oncology · doi:10.1016/j.yao.2024.02.004
Reversing the Aged Immune System with Stem Cells
Sherman, L. S., Petryna, A., Munoz, S. M., Gubenko, E. E., & Rameshwar, P. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_27
ВЛИЯНИЕ КЛОНАЛЬНОГО ГЕМАТОПОЭЗА С НЕОПРЕДЕЛЕННЫМ ПОТЕНЦИАЛОМ (CHIP) НА РАЗВИТИЕ АТЕРОСКЛЕРОЗА
Bekbossynova, M. S., Andosova, S. A., Rysbekova, A., & Daniyarova Gulnur, D. (2024) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2024.26.4.023
CHIP - Management und klinische Implikationen
Hecker, J. S., Pachzelt, L., Buck, M. C., von Scheidt, M., & Bassermann, F. C. (2024) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-024-0776-x
Ghosh, K., Iyer, R. K., Sood, S., Islam, M. S., Labad, J. G., & Khadilkar, R. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.09.632127
Grimaldi, F., Memoli, M., Avilia, S., Russo, R., Scalia, G., Visconti, R., Errichiello, S., Izzo, B., & Pane, F. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06404-z
He, X., Jia, Z.-N., Wu, J.-Z., Lv, J., Liu, Z., Liu, L., Liu, R.-L., Yuan, K., Yang, K., Li, C.-C., et al. (2025) · Discover Medicine · doi:10.1007/s44337-025-00281-1
Blood aging: From definition and mechanisms to clinical practice
Yin, Q., Zhang, Y., Yi, X., Li, J., Dai, Y., & Jin, F. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112144
Dong, Y., Guo, C., Zhou, W., Li, W., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.15132718
Grunwald, L., Große-Thie, C., Sender, S., Knuebel, G., Krohn, S., Roolf, C., Junghanss, C., Henze, L., & Escobar, H. M. (2020) · Figshare · doi:10.6084/m9.figshare.13468383
Dong, Y., Guo, C., Zhou, W., Li, W., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.15132727
Dong, Y., Guo, C., Zhou, W., Li, W., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.15132721
Dong, Y., Guo, C., Zhou, W., Li, W., & Zhang, L. (2021) · Figshare · doi:10.6084/m9.figshare.15132733
Clinical Applications of Liquid Biopsy
Kim, S. H., & Kim, Y. (2026) · Springer eBooks · doi:10.1007/978-981-99-4418-7_5
Non-Coding RNA: Architects of Cellular Complexity and Agents of Malignancy
Shah, A. (2026) · Genes · doi:10.3390/genes17030304
Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cellsPreprint
Niño, K. E., Ademà, V., Gray, A. E., Cowan, C. M., Schleicher, W. E., Hosseini, M., Bennett, S. N., Patel, S. B., Moreira, S., Danis, E. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.28.707294
Clonal hematopoiesis in the pathogenesis of non-hematologic diseases with therapeutic potential
Lei, L., & Xiong, J. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04285-4
TP53INP1 et PLZF : acteurs du vieillissement dans l’hématopoïèse
Zidi, B. (2019) · theses.fr (ABES) · doi:10.70675/4db242d6zb664z4b84z9295z1ce4d24b024e
Etude in vivo de la chimiorésistance dans les leucémies aigues myéloïdes humaines
Aroua, N. (2018) · theses.fr (ABES) · doi:10.70675/87716ea3z1f4dz4a62zb041z59f2afc4c3e9
Grenier, J. M. P. (2021) · theses.fr (ABES) · doi:10.70675/1aab1369zd34cz4476z8c46z39a2c3df85b6
Modifications du microenvironnement cytokinique dans les leucémies aigües myéloïdes
Guermouche, H. (2021) · theses.fr (ABES) · doi:10.70675/e0e649a1z9428z4e58z93b3z0b5d7ec2fea8
Clonal evolution of AML: current conceptions and clinical observations
Shatilova, A. A., Girshova, L., Budaeva, I. G., Demidov, O. N., & Belotserkovskaya, E. (2026) · Гематология и трансфузиология · doi:10.35754/0234-5730-2026-71-1-120-133
Accelerated Clonal Hematopoiesis and Premature Hematopoietic Aging in Benzene‐Exposed Populations
He, J., Zhang, L., Zhao, J., Yang, X., Wang, T., Cui, S., Cheng, X., Yang, X., Zhou, J., Li, M., et al. (2026) · American Journal of Hematology · doi:10.1002/ajh.70324
Huang, L., Lin, B., Zhu, G., Mu, Y., Li, Y., Fan, Y., Shan, G., Li, Y., Shi, M., Xia, Y., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06185-x
Xiao, J., Park, B. K., Li, Y., Wasnik, S., Fattah, F., Lee, S., Codorniz, K., Tan, L. D., Chang, A., Saca, L., et al. (2026) · Cells · doi:10.3390/cells15171521
Yao, C., Chen, Y., Tsai, B.-R., Chen, J.-W., Chan, C., Chen, W., Lin, L.-Y., Chou, W., Ho, Y., & Yang, L. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.08.052
Exacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesis
Wang, H., Hu, N., Barovic, M., Pan, B., Cheng, G., Li, X., Li, Y., Lim, J., Zhou, Y., Murray, P. J., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag248
The average individual genome: a survey of nearly 1 million whole-genome sequences
Wright, H. I. W., Beaumont, R. N., Fasham, J., Leslie, J. S., Chundru, V. K., Hall, T. S., Cannon, S. J., Pagnamenta, A. T., Baple, E. L., Wood, A. R., et al. (2026) · Genome Medicine · doi:10.1186/s13073-026-01792-x
DNA methylation in human disease: From biological mechanisms to clinical applications
Mallik, R., Gupta, P., Gupta, A. K., Chaturvedi, P., Pillai, V., & Muegge, K. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.102635
Metadata
- Authors
- Shlush, L. I.
- Affiliations
- Rambam Health Care Campus (IL)
- Corresponding author
- Shlush, Liran I.
- ORCID
- Shlush, Liran I.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2018-02-01
- Volume
- 131
- Issue
- 5
- Pages
- 496-504
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2770273110
- Cited by
- 281
- References
- 66
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 20 · 2023: 27 · 2022: 31 · 2021: 48 · 2020: 46 · 2019: 43 · 2018: 22
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- age-related clonal hematopoiesis, hematopoietic stem and progenitor cells, clonal expansion, somatic mutations, clonal evolution, hematological malignancy risk, inflammation, vascular disease, aging, B cells, T cells, hematopoietic niche
- MeSH terms
- Aging, Animals, Clone Cells, Hematopoiesis, Hematopoietic Stem Cells, Humans, Genetic Variation, Hematologic Neoplasms, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review